...
首页> 外文期刊>Source Code for Biology Medicine >Molecular-docking study of malaria drug target enzyme transketolase in Plasmodium falciparum 3D7 portends the novel approach to its treatment
【24h】

Molecular-docking study of malaria drug target enzyme transketolase in Plasmodium falciparum 3D7 portends the novel approach to its treatment

机译:恶性疟原虫3D7中疟疾药物靶酶转酮酶的分子对接研究预示了其新的治疗方法

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Malaria has been a major life threatening mosquito borne disease from long since. Unavailability of any effective vaccine and recent emergence of multi drug resistant strains of malaria pathogen Plasmodium falciparum continues to cause persistent deaths in the tropical and sub-tropical region. As a result, demands for new targets for more effective anti-malarial drugs are escalating. Transketolase is an enzyme of the pentose phosphate pathway; a novel pathway which is involved in energy generation and nucleic acid synthesis. Moreover, significant difference in homology between Plasmodium falciparum transketolase (Pftk) and human (Homo sapiens) transketolase makes it a suitable candidate for drug therapy. Our present study is aimed to predict the 3D structure of Plasmodium falciparum transketolase and design an inhibitor against it. Results The primary and secondary structural features of the protein is calculated by ProtParam and SOPMA respectively which revealed the protein is composed of 43.3 % alpha helix and 33.04 % random coils along with 15.62 % extended strands, 8.04 % beta turns. The three dimensional structure of the transketolase is constructed using homology modeling tool MODELLAR utilizing several available transketolase structures as templates. The structure is then subjected to deep optimization and validated by structure validation tools PROCHECK, VERIFY 3D, ERRAT, QMEAN. The predicted model scored 0.74 for global model reliability in PROCHECK analysis, which ensures the quality of the model. According to VERIFY 3D the predicted model scored 0.77 which determines good environmental profile along with ERRAT score of 78.313 which is below 95 % rejection limit. Protein-protein and residue–residue interaction networks are generated by STRING and RING server respectively. CASTp server was used to analyze active sites and His 109, Asn 108 and His 515 are found to be more positive site to dock the substrate, in addition molecular docking simulation with Autodock vina determined the estimated free energy of molecular binding was of ?6.6 kcal/mol for most favorable binding of 6′-Methyl-Thiamin Diphosphate. Conclusion This predicted structure of Pftk will serve first hand in the future development of effective Pftk inhibitors with potential anti-malarial activity. However, this is a preliminary study of designing an inhibitor against Plasmodium falciparum 3D7; the results await justification by in vitro and in vivo experimentations.
机译:背景技术疟疾自长期以来一直是威胁生命的主要蚊媒疾病。无法获得任何有效的疫苗以及疟疾病原体恶性疟原虫的多药耐药菌株的近期出现,继续在热带和亚热带地区造成持续性死亡。结果,对于更有效的抗疟疾药物的新目标的需求正在增加。转酮醇酶是戊糖磷酸途径的酶。与能量产生和核酸合成有关的新途径。而且,恶性疟原虫转酮醇酶(Pftk)和人(智人)转酮醇酶之间同源性的显着差异使其成为药物治疗的合适候选者。我们目前的研究旨在预测恶性疟原虫转酮醇酶的3D结构并设计针对其的抑制剂。结果该蛋白的一级和二级结构特征分别由ProtParam和SOPMA计算得出,该蛋白由43.3%的α螺旋和33.04%的无规卷曲以及15.62%的延伸链,8.04%的β匝组成。使用同源性建模工具MODELLAR,利用几种可用的转酮醇酶结构作为模板,构建转酮醇酶的三维结构。然后对该结构进行深度优化,并通过结构验证工具PROCHECK,VERIFY 3D,ERRAT,QMEAN进行验证。在PROCHECK分析中,预测模型的整体模型可靠性得分为0.74,从而确保了模型的质量。根据VERIFY 3D,预测模型的得分为0.77,可确定良好的环境状况,而ERRAT得分为78.313,低于95%的排斥极限。蛋白质-蛋白质和残基-残基相互作用网络分别由STRING和RING服务器生成。使用CASTp服务器分析活性位点,发现His 109,Asn 108和His 515是固定底物的更阳性位点,此外,利用Autodock vina进行的分子对接模拟确定了估计的分子结合自由能约为6.6 kcal。对于最有利的6'-甲基-硫胺素二磷酸酯的结合,为/ mol / mol。结论Pftk的这种预测结构将在未来开发具有潜在抗疟疾活性的有效Pftk抑制剂中发挥第一手作用。然而,这是设计抗恶性疟原虫3D7抑制剂的初步研究。结果需要通过体外和体内实验证明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号